Can European Biotech Companies Afford Not to Work with China?
In the current trade standoff between the US and China, Europe has a golden opportunity…
30/09/2019 - 4 minutes
Antoine Papiernik
Antoine Papiernik is a Managing Partner at the life sciences VC firm Sofinnova Partners. He has been an initial investor and active board member in Actelion, ProQR, NovusPharma, Movetis, Mainstay, Pixium Vision and Stentys, among others.
The Business of Biotech: What to Do When the S*#t Hits the Fan
From CEO-itis to FDA-itis, the path of a biotech company is never dull. Whether the…
16/07/2019 - 5 minutes
Is Going Public in Europe the Kiss of Death?
The key for a European biotech is to find the money where it is. And…
05/06/2019 - 6 minutes
